Beyond islet transplantation in diabetes cell therapy: from embryonic stem cells to transdifferentiation of adult cells.


Exogenous insulin is, at the moment, the therapy of choice of diabetes, but does not allow tight regulation of glucose leading to long-term complications. Recently, pancreatic islet transplantation to reconstitute insulin-producing β cells, has emerged as an alternative promising therapeutic approach. Unfortunately, the number of donor islets is too low… (More)
DOI: 10.1016/j.transproceed.2013.01.076


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics